Motion Stimulation Therapy Market Size was valued at US$ 1.1 Million in FY 2021, and is expected to grow at a 9.1% Y-o-Y growth rate until 2022, when it will be worth US$ 1.2 Million. During the forecast period of 2022 to 2032, the market is expected to grow at a CAGR of 4.1%, reaching US$ 1.8 Million.

Muscle spasms, pain relief, and inflammation reduction can all benefit from motion stimulation therapy. Motion stimulation therapy also promotes muscle contraction, which aids in the prevention of muscle atrophy. Parkinson’s disease, a progressive neurodegenerative disorder that primarily affects the elderly, can benefit from motion stimulation therapy.

Request a Sample Copy of this research@

Deep brain stimulation (DBS) is a type of movement stimulation therapy used to treat Parkinson’s disease. Deep brain stimulation is the most commonly used surgical treatment for Parkinson’s disease. Advanced motion stimulation therapies, such as functional stimulation and therapeutic electric stimulation, are also commonly used to improve outcomes and speed up recovery from muscular dysfunction. These therapies make use of devices that use electric impulses to electrically stimulate and contract muscles.

Which are Some Prominent Drivers Spearheading Motion stimulation therapy Market Growth?

The primary factor driving the growth of the motion stimulation market is the increasing prevalence of Parkinson’s disease. The rising number of traffic accidents and muscle injuries is expected to fuel the growth of the motion stimulation therapy market. Motion stimulation therapy can also be used in conjunction with standard medication.

This is known as combination therapy, and the fact that motion stimulation therapy can be used as an add-on therapy is expected to drive market growth in the motion stimulation therapy market. Technological advancements in stimulator devices are also helping to drive the growth of the motion stimulation therapy market.

The global Motion Stimulation Therapy market is expected to grow significantly during the forecast period due to an increase in government funding for the development of novel drugs. According to the Parkinson’s Association of the Carolinas, nearly 60,000 people in the United States are diagnosed with Parkinson’s disease each year, with an estimated 10 million people worldwide living with the disease.

Because of the rising prevalence of Parkinson’s disease worldwide, the functional neuromuscular stimulation therapy segment is expected to gain the most market share in the global motion stimulation therapy market. Hospitals are expected to be the most dominant end-user segment due to an increase in the number of patients seeking motion stimulation therapy.

Avail Discount@

How is North America Contributing to the Growth of the Motion stimulation therapy Market?

Because of the rising incidences of musculoskeletal disorders and rising fitness awareness, the motion stimulation therapy market is expected to grow at a CAGR of 4.8 percent during the forecast period in North America. For example, the World Health Organization (WHO) reported in February 2021 that around 1.71 billion people worldwide suffer from musculoskeletal disorders.

Because of high spending on healthcare products, favorable reimbursement policies, and increased adoption among sedentary consumers, the North American region is well-positioned to reign supreme in the global muscle stimulation devices market.

Key Companies Profiled:
Valencia CA USA, , Cyberonics, , Medtronic, , Innovative Neurotronics Inc., , Boston Scientific Corporation, , Bioness Inc., , St. Jude Medical Inc., , Nevro Corporation

Segments Covered

  • Therapy Type
  • End User

Market Competition

Valencia, CA, USA, Cyberonics, Medtronic, Innovative Neurotronics, Inc. Boston Scientific Corporation; Bioness Inc. St. Jude Medical; Inc., and Nevro Corporation are some of the key players found across the value chain of motion Stimulation therapy market. Because of the large number of participants, the market is extremely competitive.

Customization Available@

Key Segments Covered in the Motion Stimulation Therapy Market Study

Motion Stimulation Therapy Market by Therapy Type:

  • Functional Neuromuscular Motion Stimulation Therapy
  • Peripheral Motion Stimulation Therapy
  • Deep Brain Motion Stimulation Therapy
  • Therapeutic Electrical Motion Stimulation Therapy

Motion Stimulation Therapy Market by End User:

  • Motion Stimulation Therapy across Hospitals
  • Motion Stimulation Therapy across Specialty Clinics
  • Motion Stimulation Therapy across Other End User

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Leave a comment

Your email address will not be published. Required fields are marked *